Cargando…

Moyamoya Disease: Treatment and Outcomes

Although the pathogenesis of moyamoya disease (MMD) has not been fully elucidated, the effectiveness of surgical revascularization in preventing stroke has been addressed by many studies. The main mechanism of surgical revascularization is augmenting the intracranial blood flow using an external car...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tackeun, Oh, Chang Wan, Bang, Jae Seung, Kim, Jeong Eun, Cho, Won-Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Stroke Society 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747064/
https://www.ncbi.nlm.nih.gov/pubmed/26846757
http://dx.doi.org/10.5853/jos.2015.01739
_version_ 1782414913347518464
author Kim, Tackeun
Oh, Chang Wan
Bang, Jae Seung
Kim, Jeong Eun
Cho, Won-Sang
author_facet Kim, Tackeun
Oh, Chang Wan
Bang, Jae Seung
Kim, Jeong Eun
Cho, Won-Sang
author_sort Kim, Tackeun
collection PubMed
description Although the pathogenesis of moyamoya disease (MMD) has not been fully elucidated, the effectiveness of surgical revascularization in preventing stroke has been addressed by many studies. The main mechanism of surgical revascularization is augmenting the intracranial blood flow using an external carotid system by either direct bypass or pial synangiosis. This can improve resting cerebral blood flow as well as vascular reserve capacity. For direct revascularization, the superficial temporal artery is used as the donor artery in most cases, although the occipital artery may be used in limited cases. Usually, the cortical branch of the middle cerebral artery is selected as the recipient of direct anastomosis. As for indirect revascularization, various techniques using different kinds of connective tissues have been introduced. In some cases, reinforcing the anterior cerebral artery and the posterior cerebral artery territories can be considered. The effectiveness of surgical revascularization for preventing ischemic stroke had been generally accepted by many studies. However, for preventing hemorrhagic stroke, new evidence has been added by a recent randomized controlled trial. The incidence of peri-operative complications such as stroke and hyperperfusion syndrome seems to be high due to the nature of the disease and technical demands for treatment. Preventing and adequately managing these complications are essential for ensuring the benefits of surgery.
format Online
Article
Text
id pubmed-4747064
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Korean Stroke Society
record_format MEDLINE/PubMed
spelling pubmed-47470642016-02-23 Moyamoya Disease: Treatment and Outcomes Kim, Tackeun Oh, Chang Wan Bang, Jae Seung Kim, Jeong Eun Cho, Won-Sang J Stroke Special Review Although the pathogenesis of moyamoya disease (MMD) has not been fully elucidated, the effectiveness of surgical revascularization in preventing stroke has been addressed by many studies. The main mechanism of surgical revascularization is augmenting the intracranial blood flow using an external carotid system by either direct bypass or pial synangiosis. This can improve resting cerebral blood flow as well as vascular reserve capacity. For direct revascularization, the superficial temporal artery is used as the donor artery in most cases, although the occipital artery may be used in limited cases. Usually, the cortical branch of the middle cerebral artery is selected as the recipient of direct anastomosis. As for indirect revascularization, various techniques using different kinds of connective tissues have been introduced. In some cases, reinforcing the anterior cerebral artery and the posterior cerebral artery territories can be considered. The effectiveness of surgical revascularization for preventing ischemic stroke had been generally accepted by many studies. However, for preventing hemorrhagic stroke, new evidence has been added by a recent randomized controlled trial. The incidence of peri-operative complications such as stroke and hyperperfusion syndrome seems to be high due to the nature of the disease and technical demands for treatment. Preventing and adequately managing these complications are essential for ensuring the benefits of surgery. Korean Stroke Society 2016-01 2016-01-29 /pmc/articles/PMC4747064/ /pubmed/26846757 http://dx.doi.org/10.5853/jos.2015.01739 Text en Copyright © 2016 Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Special Review
Kim, Tackeun
Oh, Chang Wan
Bang, Jae Seung
Kim, Jeong Eun
Cho, Won-Sang
Moyamoya Disease: Treatment and Outcomes
title Moyamoya Disease: Treatment and Outcomes
title_full Moyamoya Disease: Treatment and Outcomes
title_fullStr Moyamoya Disease: Treatment and Outcomes
title_full_unstemmed Moyamoya Disease: Treatment and Outcomes
title_short Moyamoya Disease: Treatment and Outcomes
title_sort moyamoya disease: treatment and outcomes
topic Special Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747064/
https://www.ncbi.nlm.nih.gov/pubmed/26846757
http://dx.doi.org/10.5853/jos.2015.01739
work_keys_str_mv AT kimtackeun moyamoyadiseasetreatmentandoutcomes
AT ohchangwan moyamoyadiseasetreatmentandoutcomes
AT bangjaeseung moyamoyadiseasetreatmentandoutcomes
AT kimjeongeun moyamoyadiseasetreatmentandoutcomes
AT chowonsang moyamoyadiseasetreatmentandoutcomes